220 related articles for article (PubMed ID: 26087255)
1. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.
Traitanon O; Mathew JM; La Monica G; Xu L; Mas V; Gallon L
PLoS One; 2015; 10(6):e0129658. PubMed ID: 26087255
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells.
Kraaijeveld R; Li Y; Yan L; de Leur K; Dieterich M; Peeters AMA; Wang L; Shi Y; Baan CC
Transplant Proc; 2019 Dec; 51(10):3463-3473. PubMed ID: 31733794
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
4. Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction.
Levitsky J; Gallon L; Miller J; Tambur AR; Leventhal J; Flaa C; Huang X; Sarraj B; Wang E; Mathew JM
Transplantation; 2011 Jan; 91(2):199-206. PubMed ID: 21239962
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
[TBL] [Abstract][Full Text] [Related]
6. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
Berry V; Magill A; Yost M; Janosky J; Sindhi R
Cytometry A; 2006 Feb; 69(2):95-103. PubMed ID: 16369935
[TBL] [Abstract][Full Text] [Related]
7. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
[TBL] [Abstract][Full Text] [Related]
8. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.
Heidt S; Roelen DL; Eijsink C; van Kooten C; Claas FH; Mulder A
Transplantation; 2008 Nov; 86(9):1292-300. PubMed ID: 19005412
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients.
Li Y; Shi Y; Liao Y; Yan L; Zhang Q; Wang L
Int Immunopharmacol; 2015 Sep; 28(1):435-43. PubMed ID: 26186486
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
Chu ZQ; Ji Q
Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
[TBL] [Abstract][Full Text] [Related]
11. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.
Merino D; San Segundo D; Medina JM; Rodrigo E; Asensio E; Irure J; Fernández-Fresnedo G; Arias MA; López-Hoyos M
Immunology; 2016 Jun; 148(2):206-15. PubMed ID: 26931075
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of in vitro immune responses of T and B cells during tolerance induction by sirolimus.
Ghobrial R; Karczewski M; Ferraresso M; Tian L; Stepkowski SM; Kahan BD
Ann Transplant; 1996; 1(4):22-9. PubMed ID: 9869901
[TBL] [Abstract][Full Text] [Related]
13. Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.
Morelon E; Lefrançois N; Besson C; Prévautel J; Brunet M; Touraine JL; Badet L; Touraine-Moulin F; Thaunat O; Malcus C
Transpl Immunol; 2010 May; 23(1-2):53-8. PubMed ID: 20406686
[TBL] [Abstract][Full Text] [Related]
14. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease.
Westenfeld R; Schlieper G; Wöltje M; Gawlik A; Brandenburg V; Rutkowski P; Floege J; Jahnen-Dechent W; Ketteler M
Nephrol Dial Transplant; 2011 Dec; 26(12):4115-23. PubMed ID: 21622987
[TBL] [Abstract][Full Text] [Related]
15. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
16. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
Barten MJ; Dhein S; Chang H; Bittner HB; Tarnok A; Rahmel A; Mohr FW; Gummert JF
J Immunol Methods; 2003 Dec; 283(1-2):99-114. PubMed ID: 14659903
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses.
Levitsky J; Miller J; Huang X; Gallon L; Leventhal JR; Mathew JM
PLoS One; 2016; 11(6):e0156535. PubMed ID: 27275747
[TBL] [Abstract][Full Text] [Related]
18. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.
Kim KW; Chung BH; Kim BM; Cho ML; Yang CW
Immunology; 2015 Jan; 144(1):68-78. PubMed ID: 24974886
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
[TBL] [Abstract][Full Text] [Related]
20. Pseurotin D Inhibits the Activation of Human Lymphocytes.
Rubanova D; Dadova P; Vasicek O; Kubala L
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]